"Silverstein Eye Centers is Kansas City’s most trusted full service eye care practice that specializes in laser-assisted cataract surgery, premium lens implantation surgery, bladeless LASIK vision correction, glaucoma, diseases of the cornea and retina, treatment of dry eye and effects of diabetes. Silverstein Eye Centers has built its reputation upon delivering the highest quality medical and surgical outcomes, provided by a team of professional, ethical, and compassionate doctors and staff, supported by exceptional technology. Our practice environment is specifically designed to ensure patient comfort, warmth, and privacy. The focus, and indeed the very philosophy of this practice is based upon total patient care."

During the past decade, Silverstein Eye Centers conducted 14 clinical trials. In the 10-year time frame, 14 clinical trials started and 9 clinical trials were completed, i.e. on average, 64.3% percent of trials that started reached the finish line to date. In the past 5 years, 4 clinical trials started and 7 clinical trials were completed. i.e. 175% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Silverstein Eye Centers" #1 sponsor was "Shire" with 3 trials, followed by "Aqumen Biopharmaceuticals, N.A." with 2 trials sponsored, "Glaukos Corporation" with 2 trials sponsored, "Allergan" with 1 trials sponsored and "Andover Eye Associates" with 1 trials sponsored. Other sponsors include 9 different institutions and companies that sponsored additional 19 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Silverstein Eye Centers" #1 collaborator was "Bausch & Lomb Incorporated" with 1 trials as a collaborator, "National Eye Institute (NEI)" with 1 trials as a collaborator, "Ocular Therapeutix, Inc." with 1 trials as a collaborator, "Regeneron Pharmaceuticals" with 1 trials as a collaborator and "Statistics & Data Corporation" with 1 trials as a collaborator. Other collaborators include -4 different institutions and companies that were collaborators in the rest 6 trials.

According to Clinical.Site data, the most researched conditions in "Silverstein Eye Centers" are "Cataract" (4 trials), "Dry Eye" (2 trials), "Mature Cataracts" (2 trials), "Acute Adenoviral Conjunctivitis" (1 trials) and "Adenoviral Conjunctivitis" (1 trials). Many other conditions were trialed in "Silverstein Eye Centers" in a lesser frequency.

Most popular intervention types in "Silverstein Eye Centers" are "Drug" (19 trials), "Device" (5 trials), "Other" (3 trials) and "Procedure" (2 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (5 trials), "Vehicle" (4 trials), "DYME" (2 trials), "SHP640" (2 trials) and "AzaSite®" (1 trials). Other intervention names were less common.

The vast majority of trials in "Silverstein Eye Centers" are 23 trials for "All" genders.

Currently, there are NaN active trials in "Silverstein Eye Centers". undefined are not yet recruiting, 2 are recruiting, 2 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 13 completed trials in Silverstein Eye Centers, undefined suspended trials, and 3 terminated clinical trials to date.

Out of the total trials that were conducted in Silverstein Eye Centers, 1 "Phase 1" clinical trials were conducted, 4 "Phase 2" clinical trials and 14 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 2 trials, and there were also 2 trials that are defined as “Not Applicable".